AllTrials – Pharma company investors call for clinical trials transparency
"Today investors representing more than €3.5 trillion in assets are asking the pharmaceutical companies they invest in to move towards transparency. The groups of 85 pension funds and asset managers support the aims of the AllTrials campaign and want the pharma companies to set out their plans to get clinical trials, past, present and future, registered and results reported ... BNP Paribas Investment Partners worked with AllTrials to bring together the group which includes RobecoSAM, Aviva Investors, Boston Commons Asset Management, 65 UK local authority pension funds and the investment arm of the Wellcome Trust. We held a series of workshops with investors in Europe and the US over the last 6 months to develop the practical steps they are today writing to companies to ask them to take. These steps include  Retrospectively registering past and ongoing clinical trials, and registering all future trials before they begin  Publishing the methods and full results of all trials, including information on adverse events  Posting an objective summary of results within one year of completion of the trial, following the guidelines on ClinicalTrials.gov  Supporting efforts to provide independent researchers access to anonymised individual patient data ..."